Aminocaproic Acid Decreases Secondary Hemorrhage After Traumatic Hyphema

John J. Mcgetrick, Lee M. Jampol, Morton F Goldberg, Marcel Frenkel, Richard G. Fiscella

Research output: Contribution to journalArticle

Abstract

Forty-eight patients (49 eyes) had nonperforating traumatic hyphema. Twenty-eight patients (28 eyes with hyphema) received oral aminocaproic acid, an antifibrinolytic agent, in a dosage of 100 mg/kg every four hours for five days, up to a maximum daily dose of 30 g. Twenty patients (21 eyes with hyphema) received placebo in an identical regimen. One eye treated with aminocaproic acid rebled; seven eyes receiving the placebo rebled. The results of this study show a statistically significant reduction in the incidence of secondary hemorrhage in the patients receiving aminocaproic acid.

Original languageEnglish (US)
Pages (from-to)1031-1033
Number of pages3
JournalArchives of Ophthalmology
Volume101
Issue number7
DOIs
StatePublished - 1983
Externally publishedYes

Fingerprint

Hyphema
Aminocaproic Acid
Hemorrhage
Placebos
Antifibrinolytic Agents
Incidence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Aminocaproic Acid Decreases Secondary Hemorrhage After Traumatic Hyphema. / Mcgetrick, John J.; Jampol, Lee M.; Goldberg, Morton F; Frenkel, Marcel; Fiscella, Richard G.

In: Archives of Ophthalmology, Vol. 101, No. 7, 1983, p. 1031-1033.

Research output: Contribution to journalArticle

Mcgetrick, John J. ; Jampol, Lee M. ; Goldberg, Morton F ; Frenkel, Marcel ; Fiscella, Richard G. / Aminocaproic Acid Decreases Secondary Hemorrhage After Traumatic Hyphema. In: Archives of Ophthalmology. 1983 ; Vol. 101, No. 7. pp. 1031-1033.
@article{2f925349124543fb8e3ef3bb89bc3744,
title = "Aminocaproic Acid Decreases Secondary Hemorrhage After Traumatic Hyphema",
abstract = "Forty-eight patients (49 eyes) had nonperforating traumatic hyphema. Twenty-eight patients (28 eyes with hyphema) received oral aminocaproic acid, an antifibrinolytic agent, in a dosage of 100 mg/kg every four hours for five days, up to a maximum daily dose of 30 g. Twenty patients (21 eyes with hyphema) received placebo in an identical regimen. One eye treated with aminocaproic acid rebled; seven eyes receiving the placebo rebled. The results of this study show a statistically significant reduction in the incidence of secondary hemorrhage in the patients receiving aminocaproic acid.",
author = "Mcgetrick, {John J.} and Jampol, {Lee M.} and Goldberg, {Morton F} and Marcel Frenkel and Fiscella, {Richard G.}",
year = "1983",
doi = "10.1001/archopht.1983.01040020033003",
language = "English (US)",
volume = "101",
pages = "1031--1033",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "7",

}

TY - JOUR

T1 - Aminocaproic Acid Decreases Secondary Hemorrhage After Traumatic Hyphema

AU - Mcgetrick, John J.

AU - Jampol, Lee M.

AU - Goldberg, Morton F

AU - Frenkel, Marcel

AU - Fiscella, Richard G.

PY - 1983

Y1 - 1983

N2 - Forty-eight patients (49 eyes) had nonperforating traumatic hyphema. Twenty-eight patients (28 eyes with hyphema) received oral aminocaproic acid, an antifibrinolytic agent, in a dosage of 100 mg/kg every four hours for five days, up to a maximum daily dose of 30 g. Twenty patients (21 eyes with hyphema) received placebo in an identical regimen. One eye treated with aminocaproic acid rebled; seven eyes receiving the placebo rebled. The results of this study show a statistically significant reduction in the incidence of secondary hemorrhage in the patients receiving aminocaproic acid.

AB - Forty-eight patients (49 eyes) had nonperforating traumatic hyphema. Twenty-eight patients (28 eyes with hyphema) received oral aminocaproic acid, an antifibrinolytic agent, in a dosage of 100 mg/kg every four hours for five days, up to a maximum daily dose of 30 g. Twenty patients (21 eyes with hyphema) received placebo in an identical regimen. One eye treated with aminocaproic acid rebled; seven eyes receiving the placebo rebled. The results of this study show a statistically significant reduction in the incidence of secondary hemorrhage in the patients receiving aminocaproic acid.

UR - http://www.scopus.com/inward/record.url?scp=0020593928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020593928&partnerID=8YFLogxK

U2 - 10.1001/archopht.1983.01040020033003

DO - 10.1001/archopht.1983.01040020033003

M3 - Article

C2 - 6870623

AN - SCOPUS:0020593928

VL - 101

SP - 1031

EP - 1033

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 7

ER -